Michael Castagna

Michael Castagna

Chief Executive Officer at MANNKIND CORPORATION

Net worth: 8 M $ as of 27/02/2026

49 year
Health Technology
Consumer Services
Process Industries

Profile

Michael E.
Castagna
currently works at MannKind Corp., as Chief Executive Officer & Director from 2017, scPharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2025, and Pet Partners, as Director.
Dr. Castagna also formerly worked at Bristol Myers Squibb Co., as Executive Director-Immunology Franchise from 2010 to 2012, Pharmasset, Inc., as Director, Amgen, Inc., as Vice President-Global Commercial from 2012 to 2016, Sandoz, Inc., as Vice President & Head-Biopharmaceuticals from 2009 to 2010, and Novartis AG, as VP & Head-North America Biopharmaceuticals.
Dr. Castagna received his doctorate degree in 2014 from Massachusetts College of Pharmacy & Health Science, Masters Business Admin degree in 2005 from The Wharton School of the University of Pennsylvania, and undergraduate degree in 2000 from Philadelphia College of Pharmacy.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
22/03/2026 2,577,411 ( 0.84% ) 8 M $ 27/02/2026

Michael Castagna active positions

CompaniesPositionStart
MANNKIND CORPORATION Chief Executive Officer 24/05/2017
SCPHARMACEUTICALS INC. Chief Executive Officer 06/10/2025
Director/Board Member -

Former positions of Michael Castagna

CompaniesPositionEnd
AMGEN INC. Corporate Officer/Principal 13/03/2016
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 31/10/2012
Corporate Officer/Principal 31/10/2010
Director/Board Member -
NOVARTIS AG Corporate Officer/Principal -
See the detail of Michael Castagna's experience

Training of Michael Castagna

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Process Industries

  1. Stock Market
  2. Insiders
  3. Michael Castagna